PDT Partners, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$570,000
+45.0%
45,605
-42.7%
0.09%
+145.7%
Q2 2022$393,000
-64.9%
79,537
+55.7%
0.04%
-52.7%
Q2 2021$1,121,000
-49.6%
51,094
-44.7%
0.07%
-53.8%
Q1 2021$2,223,000
+25.2%
92,406
-6.4%
0.16%
+33.3%
Q4 2020$1,776,000
+9.9%
98,725
-29.4%
0.12%
+12.1%
Q3 2020$1,616,000
+62.7%
139,924
+242.0%
0.11%
+57.4%
Q2 2020$993,00040,9190.07%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders